Impact of taxanes on androgen receptor signaling

The development and progression of metastatic castration-resistant prostate cancer is the major challenge in the treatment of advanced prostate cancer. The androgen receptor signaling pathway remains active in metastatic castration-resistant prostate cancer. Docetaxel and cabazitaxel are the first-...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Shanshan, Zhang, Bryan Y, Dong, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Invited Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498725/
https://www.ncbi.nlm.nih.gov/pubmed/29900882
http://dx.doi.org/10.4103/aja.aja_37_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498725/
https://www.ncbi.nlm.nih.gov/pubmed/29900882
http://dx.doi.org/10.4103/aja.aja_37_18

Ejemplares similares